Skip to content

Evaluation of a New Metal Biliary Stent of 12-mm Diameter: a Case Control Study

Evaluation of a New Metal Biliary Stent of 12-mm Diameter: a Case Control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04405752
Acronym
BIGDIAM
Enrollment
72
Registered
2020-05-28
Start date
2017-04-01
Completion date
2018-04-01
Last updated
2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Biliary Obstruction

Keywords

biliary stent, malignant biliary stenosis

Brief summary

Biliary stent allows the drainage of the bile ducts palliatively or preoperatively in the event of malignant biliary stenosis, and a biliary calibration in the event of benign stenosis. Currently, by expert agreement, the diameter is 10-mm for metal stent. Since 2017, larger stents have been marketed in France and are approved for the biliary drainage of benign and malignant biliary stricture. These new 12-mm diameter stent could reduce the risk of recurrent biliary obstruction (RBO) and therefore increase the stent duration. The aim of our study was to compare whether the permeability of 12-mm diameter stent was better than a conventional 10-mm, covered or uncovered prosthesis depending on the indication.

Interventions

DEVICE12-mm metallic biliary stent

Metallic biliary stent, covered or uncovered,KEBOMED HILZO 12mm in diameter (length 4 or 6 cm).

DEVICE10-mm metallic biliary stent

Biliary, metallic, covered or uncovered stent, COOK EVOLUTION 10mm in diameter (length 4 or 6 cm)

Sponsors

Institut Paoli-Calmettes
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* benign and malignant biliary stricture of the lower or median portion of the main biliary duct with indication of biliary stent placement including pre-operatively drainage * age≥ 18 years old; * Karnofsky score ≥ 40.

Exclusion criteria

* hilar stenosis; * coagulation disorder (PT \<50%, platelets \< 80,000).

Design outcomes

Primary

MeasureTime frameDescription
Time to recurrent biliary obstruction (RBO)12 monthsRBO is defined as the time from the prosthesis deployment to until the first biliary stent obstruction (patency

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026